Dilon Technologies Inc.
  1. Companies
  2. Dilon Technologies Inc.
  3. News
  4. Director of Breast Surgery at NAPBC ...

Director of Breast Surgery at NAPBC Accredited Facility Realizes Clinical Value of MarginProbe® in Very First Case

SHARE
Dec. 2, 2019

The new Director of Breast Surgery and Women’s Health for the breast surgery center at the Albert Einstein Healthcare Network has a very simple reason for dedicating his life to his profession. “I became a surgeon because when I see a problem, I want to fix it, and with surgery we’re often the last line of defense when dealing with breast cancer,” Dr. Archit Naik admitted. “But it’s also personal for me. I went through breast cancer with a family member, including chemotherapy, the return of the disease and how it impacted the lives of everyone around it. Treating this disease is something I’m very passionate about. I enjoy waking up every day and treating patients because I’ve been there and now I know that it can be cured and it’s great to be able to do that.” Motivated by his personal encounter with breast cancer, Dr. Naik has embraced innovative techniques and technologies which improve his patients’ experience and care. For example, transitioning to a wireless tumor localization approach improves the comfort of his patients by avoiding the painful and cumbersome wire. Further, using state of the art magnetic tracers which are administered days before the actual surgery eliminates early morning arrival and lengthy, anxiety-producing waits on surgery day. Beyond technology, Dr. Naik has incorporated oncoplastic techniques into his lumpectomy surgery, focused exclusively on maintaining and improving cosmetic appearance of the patients breast post-surgery. Dr. Naik has also added a genetics counselor to his team, enabling a more tailored treatment approach for patients. In the past month alone, the surgical plans for two patients evolved due to 30 percent higher risk of cancer identified through genetic testing. “This is breast cancer that we would have never found on our own,” the surgeon explained. “And just knowing that, it’s pretty amazing and I think it’s the new frontier in high-risk surveillance that can really help us to save lives.”